Genentech

FUZEON

Manufacturer:

Genentech

Fuzeon HCPCS:

J1324

HCPCS Code Descriptor:

Injection, enfuvirtide, 1 mg

Category:

J Code

Fuzeon NDCs:

00004-0381-40

Primary Type:

Anti-HIV

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Fuzeon:

FUZEON is an Anti-HIV drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J1324 is aligned to the drug FUZEON.

ACCESS PRICING AND MORE BY REGISTERING

J1324 Added Date:

January 1, 2007

J1324 Effective Date:

January 1, 2018

J1324 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Fuzeon billing and coding information.
Fuzeon patient assistance information can be found through Genentech at the URL: https://www.fuzeon.com/
FUZEON prescribing information can be found at the link below:
Information regarding FUZEON’s side effects can be found at MedlinePlus